Krieg A - Search Results

1

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.

Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. Mahotka C, et al. Among authors: krieg t, krieg a. Int J Cancer. 2002 Jul 1;100(1):30-6. doi: 10.1002/ijc.10450. Int J Cancer. 2002. PMID: 12115583 Free article.

2

Novel survivin-related members of the inhibitor of apoptosis (IAP) family.

Wenzel M, Mahotka C, Krieg A, Bachmann A, Schmitt M, Gabbert HE, Gerharz CD. Wenzel M, et al. Among authors: krieg a. Cell Death Differ. 2000 Jul;7(7):682-3. doi: 10.1038/sj.cdd.4400691. Cell Death Differ. 2000. PMID: 11023343 No abstract available.

3

Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan.

Déjosez M, Ramp U, Mahotka C, Krieg A, Walczak H, Gabbert HE, Gerharz CD. Déjosez M, et al. Among authors: krieg a. Cell Death Differ. 2000 Nov;7(11):1127-36. doi: 10.1038/sj.cdd.4400746. Cell Death Differ. 2000. PMID: 11139287

4

Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.

Krieg A, Mahotka C, Krieg T, Grabsch H, Müller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. Krieg A, et al. Among authors: krieg t. Br J Cancer. 2002 Mar 4;86(5):737-43. doi: 10.1038/sj.bjc.6600153. Br J Cancer. 2002. PMID: 11875736 Free PMC article.

5

TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential.

Krieg A, Krieg T, Wenzel M, Schmitt M, Ramp U, Fang B, Gabbert HE, Gerharz CD, Mahotka C. Krieg A, et al. Among authors: krieg t. Br J Cancer. 2003 Mar 24;88(6):918-27. doi: 10.1038/sj.bjc.6600772. Br J Cancer. 2003. PMID: 12644830 Free PMC article.

6

Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.

Ramp U, Caliskan E, Mahotka C, Krieg A, Heikaus S, Gabbert HE, Gerharz CD. Ramp U, et al. Among authors: krieg a. Br J Cancer. 2003 Jun 2;88(11):1800-7. doi: 10.1038/sj.bjc.6600984. Br J Cancer. 2003. PMID: 12771998 Free PMC article.

7

TRAIL-R4-beta: a new splice variant of TRAIL-receptor 4 lacking the cysteine rich domain 1.

Krieg A, Schulte am Esch J 2nd, Ramp U, Hosch SB, Knoefel WT, Gabbert HE, Mahotka C. Krieg A, et al. Biochem Biophys Res Commun. 2006 Oct 13;349(1):115-21. doi: 10.1016/j.bbrc.2006.08.031. Epub 2006 Aug 14. Biochem Biophys Res Commun. 2006. PMID: 16934748

8

Expression of TRAIL-splice variants in gastric carcinomas: identification of TRAIL-γ as a prognostic marker.

Krieg A, Mersch S, Wolf N, Stoecklein NH, Verde PE, am Esch JS 2nd, Heikaus S, Gabbert HE, Knoefel WT, Mahotka C. Krieg A, et al. BMC Cancer. 2013 Aug 12;13:384. doi: 10.1186/1471-2407-13-384. BMC Cancer. 2013. PMID: 23937794 Free PMC article.

9

CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.

Krieg A, Riemer JC, Telan LA, Gabbert HE, Knoefel WT. Krieg A, et al. PLoS One. 2015 Jun 19;10(6):e0130192. doi: 10.1371/journal.pone.0130192. eCollection 2015. PLoS One. 2015. PMID: 26091099 Free PMC article.

10

Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.

Mersch S, Riemer JC, Schlünder PM, Ghadimi MP, Ashmawy H, Möhlendick B, Topp SA, Arent T, Kröpil P, Stoecklein NH, Gabbert HE, Knoefel WT, Krieg A. Mersch S, et al. Among authors: krieg a. Tumour Biol. 2016 Feb;37(2):2341-51. doi: 10.1007/s13277-015-4050-6. Epub 2015 Sep 15. Tumour Biol. 2016. PMID: 26373732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

619 results

Search Page